VJOncology is committed to improving our service to you

ESMO 2019 | Combination therapy in gynecoligcal cancer

VJOncology is committed to improving our service to you

Mansoor Raza Mirza

Mansoor Raza Mirza, MD, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, speaks on the FDA approval of lenvatonib and the future of combination immunotherapy in endometrial cancers. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter